Results 121 to 130 of about 86,397 (161)

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt, Christa M. Cobbaert, L. Renee Ruhaak   +2 more
wiley   +1 more source

Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England [PDF]

, 2015
Athanasiou, T, Bottle, R, Bouras, G, Burns, EM, Darzi, A, Howell, A   +5 more
core   +1 more source

Surgical Management of a High‐Grade Gastrointestinal Stromal Tumor in a Morbidly Obese Patient: A Case Study

Medicine Advances, EarlyView.
This case study details the successful resection of a GEJ GIST in a high body mass index patient using an innovative surgical approach. Given the increasing prevalence of obesity, understanding and improving surgical approaches in these patients becomes paramount in preventing surgical morbidity. ABSTRACT Gastrointestinal stromal tumors (GISTs) are the
Felipe Quistian, Kristen M. Quinn, Michael A. Deal, Rana Pullatt   +3 more
wiley   +1 more source

Risk factors associated with venous thromboembolism in tuberculosis: A case control study

The Clinical Respiratory Journal, Volume 16, Issue 12, Page 835-841, December 2022., 2022
Venous thromboembolism (VTE) risks seem higher in tuberculosis (TB) patients, and therefore, there is a need for active prevention and treatment. Patients with fever, dyspnea, lower limb edema, and D‐dimer levels of more than 1855 μg/L should be actively screened for VTE and prophylactic anticoagulation given if necessary.
Guo Yi Nan, He Fei, Wang Zhen, Duan Tian Yun   +3 more
wiley   +1 more source

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism

Clinical and Translational Science, Volume 16, Issue 1, Page 128-139, January 2023., 2023
Abstract Guidelines recommend an extended course of anticoagulation therapy for patients who experienced venous thromboembolism (VTE) without transient provocation, however, optimal duration remains uncertain. We assessed effectiveness and safety of extended use of apixaban and warfarin greater than 6 months of initial treatment in patients with VTE ...
Haesuk Park, Hye‐Rim Kang, Pei‐Lin Huang, Wei‐Hsuan Lo‐Ciganic, Christina E. DeRemer, Debbie Wilson, Eric A. Dietrich   +6 more
wiley   +1 more source

Low‐Intensity Focused Ultrasound‐Responsive Nanobubbles Enhance Thrombus Targeting and Penetration for Highly Effective Thrombolytic Therapy

Small Structures, EarlyView.
Low‐intensity focused ultrasound (LIFU)‐responsive nanobubbles (PAF@M) specifically target thrombus sites and penetrate thrombi under LIFU stimulation. Meanwhile, the liquid–gas phase transition of perfluoropentane and the release of nitric oxide synergistically enhance ultrasonic cavitation to destroy thrombus structure, providing a safe and effective
Wenli Zhang, Maoyuan Sun, Lian Xu, Sijin Chen, Xiyue Rong, Junrui Wang, Jia Liu, Bo Liu, Jie Xu, Ying Luo, Qianying Du, Yi Wang, Yun Liu, Zhigang Wang, Haitao Ran, Dajing Guo   +15 more
wiley   +1 more source

Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Etrasimod is an oral, once‐daily (q.d.), selective sphingosine 1‐phosphate (S1P)1,4,5 receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). Unlike the S1P receptor modulator ozanimod, etrasimod does not have a molecular structure to inhibit monoamine oxidase (MAO).
Anita Afzali, Miguel Regueiro, Andres J. Yarur, Yamile Zabana, Siew C. Ng, Sujatha Menon, Aoibhinn McDonnell, Krisztina Lazin, Michael Keating, Abhishek Bhattacharjee, Diogo Branquinho, Eustratios Bananis, Laurent Peyrin‐Biroulet   +12 more
wiley   +1 more source

Sex‐specific and hormone‐related differences in vascular remodelling in atherosclerosis

European Journal of Clinical Investigation, Volume 53, Issue 1, January 2023., 2023
Abstract Atherosclerosis, a lipid‐driven inflammatory disease, is the main underlying cause of cardiovascular diseases (CVDs) both in men and women. Sex‐related dimorphisms regarding CVDs and atherosclerosis were observed since more than a decade ago.
Anaïs Yerly, Emiel P. C. van der Vorst, Iris Baumgartner, Sarah Maike Bernhard, Marc Schindewolf, Yvonne Döring   +5 more
wiley   +1 more source

CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Venous thromboembolism (VTE) is a recognized complication of acutely ill patients, but its incidence and risk factors in those with cirrhosis are uncertain. Methods We retrospectively studied a consecutive cohort of cirrhosis patients non‐electively admitted to our medical unit to determine the rates of symptomatic VTE during
Alberto Zanetto, Alessandro Vitale, Filippo Pelizzaro, Vittorio Simeon, Elena Campello, Laura Turco, Lorenz Balcar, Francesco Paolo Russo, Patrizia Burra, Paolo Simioni, Marco Senzolo   +10 more
wiley   +1 more source

Venous thromboembolism related to cytomegalovirus infection: A case report and literature review [PDF]

, 2017
Farrell, John J, Jacob, Kavitha S, Kelkar, Amar H, Yousif, Eman B   +3 more
core   +2 more sources